INDV
NEUTRALIndivior Announces Holding(s) in Company
The healthcare company has announced a change in major shareholding, with Barclays PLC crossing below the minimum threshold for reporting.
Indivior
1,238.00GBX
1.56%
Market Cap
1.54B
Volume
16.42M
5397% of avg
P/E Ratio
967.19
EPS (TTM)
1.28
Beta
0.26
Day Range
0.00p - 0.00p
52 Week Range
0.00p1,238.00p1,228.00p
1,238.00p
Upcoming Events
INDV
NEUTRALIndivior Sees Major Shareholding Change
The healthcare company has reported a change in major shareholding, with Barclays PLC now holding a 5.39% stake.
INDV
NEUTRALIndivior Announces Change in Major Shareholding
The healthcare company has announced a change in major shareholding, with Barclays PLC now holding a 6.68% stake in the firm.
INDV
NEUTRALIndivior PLC Announces Major Shareholder Disclosure
The healthcare company has received a notification from a major shareholder regarding their voting rights position.
INDV
NEUTRALIndivior PLC Announces Major Shareholder Disclosure
The healthcare company has received a notification from a major shareholder regarding their shareholding position.
INDV
NEUTRALIndivior PLC Announces Major Shareholder Disclosure
The healthcare company has received a notification from a major shareholder regarding their shareholding position.
INDV
NEUTRALIndivior to Report Second Quarter 2025 Financial Results
The pharmaceutical company will report its Q2 2025 financial results and host a webcast on July 31st.
INDV
NEUTRALIndivior Announces Holding Change
The healthcare company has announced a change in major shareholding, with Millennium International Management LP increasing its stake.
INDV
NEUTRALIndivior Announces Major Shareholder Disclosure
The healthcare company has received a notification from a major shareholder regarding their shareholding in the business.
INDV
NEUTRALIndivior PLC Announces Holding(s) in Company
The healthcare company has announced a change in major shareholding, with Barclays PLC crossing below the minimum threshold for reporting.